Full-Time

Utilities Engineering Technician

Posted on 8/14/2025

PCI Pharma Services

PCI Pharma Services

1-10 employees

Pharmaceutical packaging and contract services

No salary listed

Cardiff, UK

In Person

Category
Mechanical Engineering (1)
Requirements
  • To work within the Engineering department to provide technical guidance and expertise in the resolution of quality issues.
  • To install and maintain the site services in a new or existing building across all of the PCI Tredegar sites in accordance with the Engineering PPM System. These services include however, are not limited to, all equipment and materials involved with heating, lighting, ventilation (HVAC), air-conditioning, electrical distribution, water supply, steam/boiler systems, sanitation, public health, fire protection, safety systems, lifts and escalators as well as all facility and utility related services.
  • To support the Engineering Departments in ensuring that all Engineering activities on the Tredegar site are completed and undertaken in compliance with current Good Manufacturing Practice standards in accordance with company policies to meet business requirements.
  • To promptly attend Facility and Utility breakdowns, practices systematic fault diagnosis and repairs in optimum time, ensuring minimum downtime and product loss.
  • Responsible for the maintenance and services all equipment and materials involved with however, not limited to heating, lighting, ventilation (HVAC), air-conditioning, electrical distribution, water supply, steam/boiler systems, sanitation, public health, fire protection, safety systems, lifts and escalators as well as all facility and utility related services.
  • Undertake the maintenance and repair of plant and/or office facilities and associated utilities at the PCI Tredegar sites.
  • Fully contributing to planned preventative maintenance programs whilst adhering to SOP’s and completing necessary documentation ensuring skilled judgements are made to ensure plant is maintained to optimum level.
  • Monitor performance of critical utilities and process equipment in cGMP environment and perform or arrange necessary repairs, adjustments, calibrations, and preventative maintenance, including maintaining appropriate documentation.
  • Liaise with onsite departments to arrange for planned preventative maintenance / rectification work required for breakdowns.
  • Liaise with third party contractors in order to arrange for planned preventative maintenance / rectification work required for breakdowns and to then ensure the prompt return of associated reports.
Desired Qualifications
  • Understanding of GMP is desirable.
  • Experience in a relevant industrial environment.
  • Degree qualification in relevant engineering degree (ideally mechanical).
  • Previous experience in Engineering function (ideally pharmaceutical or FMCG manufacturing environment covering mechanical, electrical or utilities.)
  • Attention to detail.

PCI Pharma Services offers end-to-end pharmaceutical packaging and related services, including Folding Cartons, Labels, Contract Packaging, Clinical Services, and Brand Protection. It serves as a one-stop source for healthcare product developers and manufacturers, handling carton and label production, packaging operations, clinical services, and brand protection under one roof. The company stands out with eight decades of experience, strict cGMP and ISO compliance, lean manufacturing, ongoing R&D, and comprehensive employee training, security, hygiene, and inspection practices. Its goal is to be a trusted, end-to-end packaging partner that delivers reliable, compliant, and scalable packaging solutions, so clients can focus on their core business.

Company Size

1-10

Company Stage

Debt Financing

Total Funding

$4B

Headquarters

Burlington, Canada

Founded

1971

Simplify Jobs

Simplify's Take

What believers are saying

  • GLP-1 surge drives demand for PCI's prefilled syringes and autoinjectors.
  • Oncology-CNS pipelines favor PCI's patient-centric drug-device combinations.
  • Bain Capital's $10B valuation fuels $1B capacity expansions through 2028.

What critics are saying

  • San Diego isolator line delays to H1 2028 cede contracts to Lonza.
  • Novo Nordisk's Catalent acquisition slashes external CDMO fill-finish availability.
  • PE backers force divestitures if biotech funding dries post-2025.

What makes PCI Pharma Services unique

  • PCI integrates sterile fill-finish with drug-device assembly for end-to-end injectables.
  • Ajinomoto Althea acquisition adds rare US high-potent ADC sterile filling expertise.
  • AVI systems inspect 75 million vials annually, scaling quality without bottlenecks.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

401(k) Retirement Plan

Health Savings Account/Flexible Spending Account

Company News

BioProcess International
Aug 15th, 2025
Building a better facility: BPI tours PCI manufacturing plant in Bedford

On the last day of June 2025's BIO conference in Boston, Massachusetts, contract development and manufacturing organization (CDMO) PCI Pharma Services bused a crowd of delegates to its manufacturing site in Bedford, New Hampshire where it hosted a tour of its 50,000 square-foot expansion.

Montgomery County
Jul 24th, 2025
PCI Pharma Services Valued at $10B

PCI Pharma Services in Northeast Philadelphia has received a multibillion-dollar investment from Bain Capital and Kohlberg, valuing the company at $10 billion. Kohlberg had previously invested in PCI, while Bain is a new investor. The investment will help PCI expand its services and geographic reach. The company currently operates 38 sites across seven countries and employs over 7,500 people.

JD Supra
Jul 16th, 2025
Healthcare & Life Sciences Private Equity Deal Tracker: Bain Capital and Kohlberg Invest in PCI Pharma

Healthcare & life sciences Private Equity deal tracker: Bain Capital and Kohlberg invest in PCI Pharma.

FinSMEs
Jul 15th, 2025
PCI Pharma Services Receives Investment from Mubadala, Bain Capital, and Kohlberg

PCI Pharma, a Philadelphia, PA-based contract development and manufacturing organization (CDMO) focused on biotherapies, received an investment from Bain Capital, Kohlberg, and Mubadala Investment Company.

MarketScreener
Jul 14th, 2025
PCI Pharma Services receives new funding

PCI Pharma Services announced it received a new round of funding on July 14, 2025. The funding was co-led by new investor Bain Capital, LP, and returning investor Kohlberg & Company, L.L.C. Additional participation came from returning investors Mubadala Investment Company PJSC and Partners Group Holding AG.

INACTIVE